Labcorp to introduce combined oncology offering at 2021 ASCO® annual meeting

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 2, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the introduction of its combined Labcorp oncology platform at the virtual 2021 American Society of Clinical Oncology (ASCO®) Annual Meeting held June 4-8 .

OmniSeq receives New York state approval for OmniSeq INSIGHT genomic and immune profiling test

BUFFALO, N.Y., April 28, 2021 - OmniSeq®, an innovator in next generation sequencing in oncology, today announced the New York State Department of Health's Clinical Laboratory Evaluation Program has approved the OmniSeq INSIGHTSM  test. The test detects genomic variants, genomic signatures, and immune gene expression, providing physicians with clinically actionable evidence to inform therapeutic treatment decisions and identify potential clinical trial options for patients with late-stage solid tumor cancers.

Presage sets the stage for commercial expansion with $13M financing and new Phase 0 trial agreements with Merck and Maverick Therapeutics

Seattle, WA – March 2, 2021 – Presage Biosciences, a biotechnology company pioneering a new cancer drug development approach using its Comparative In Vivo Oncology (CIVO®) intratumoral microdosing platform, today announced a $13 million financing and new research collaborations with Merck (NYSE:MRK) and Maverick Therapeutics.

Labcorp and HealthEC launch transformative oncology care module

BURLINGTON, N.C. & EDISON, N.J. --(BUSINESS WIRE)--Oct. 9, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and HealthEC, LLC , a leading provider of population health management solutions, today announced the launch of LabCorp’s Care Intelligence Oncology Module (Oncology Care Module). LabCorp’s Oncology Care Module is designed to empower oncologists to improve patient outcomes and achieve cost-savings by making it easier to access and compare key data points and performance metrics. Available exclusively through LabCorp , the single-platform solution connects claims and clinical systems using the LabCorp Care Intelligence™ application, powered by HealthEC®.

New non-invasive test for lung cancer available exclusively from Labcorp

Blood-based test guides treatment decisions for patients with non-small cell lung cancer